Stockscreener 앱 받기
1.72
9.95%
-0.19
시간 외 거래:
1.78
0.06
+3.49%
전일 마감가:
$1.91
열려 있는:
$1.95
하루 거래량:
713.58K
Relative Volume:
0.99
시가총액:
$117.60M
수익:
-
순이익/손실:
$-60.36M
주가수익비율:
-0.3914
EPS:
-4.394
순현금흐름:
$-15.05M
1주 성능:
+32.31%
1개월 성능:
+52.21%
6개월 성능:
-3.91%
1년 성능:
-50.72%
1일 변동 폭
$1.71
$1.9754
1주일 범위
$1.26
$2.18
52주 변동 폭
$0.97
$5.07
Zura Bio Ltd Stock (ZURA) Company Profile
명칭
Zura Bio Ltd
전화
858-247-0520
주소
4225 EXECUTIVE SQUARE, LA JOLLA
ZURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZURA
Zura Bio Ltd
|
1.72 | 80.44M | 0 | -60.36M | -15.05M | -4.394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Zura Bio Ltd Stock (ZURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-04 | 개시 | Leerink Partners | Outperform |
| 2024-09-05 | 개시 | H.C. Wainwright | Neutral |
| 2024-05-03 | 개시 | Piper Sandler | Overweight |
| 2023-10-10 | 개시 | Ladenburg Thalmann | Buy |
| 2023-08-25 | 개시 | Oppenheimer | Outperform |
| 2023-06-22 | 개시 | Guggenheim | Buy |
| 2023-06-14 | 개시 | Chardan Capital Markets | Buy |
| 2023-05-24 | 개시 | Raymond James | Strong Buy |
모두보기
Zura Bio Ltd 주식(ZURA)의 최신 뉴스
What analysts say about Zura Bio Limited stockOutstanding capital appreciation - Jammu Links News
H.C. Wainwright reiterates Neutral rating on Zura Bio stock amid BAFF inhibitor concerns - Investing.com Australia
Zura Bio Limited Stock Analysis and ForecastFree Predictions - Jammu Links News
3 Penny Stocks With Market Caps Over $70M Worth Watching - simplywall.st
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Zura Bio Surges 30% in Volatile Intraday Session: What's Fueling the Momentum? - AInvest
Jessica Chen - White & Case LLP
What makes Zura Bio Limited stock price move sharplyConsistent Growth Alert - Newser
Why Zura Bio Limited stock attracts strong analyst attentionFree Access to Community with 300% Return - Newser
How Zura Bio Limited stock performs during market volatilityProven Return Strategy Execution - Newser
We're Not Very Worried About Zura Bio's (NASDAQ:ZURA) Cash Burn Rate - Yahoo Finance
The ZURA Stock Puzzle: Unraveling Zura Bio Ltd’s Fluctuating Performance - investchronicle.com
Zura Bio appoints Eric Hyllengren as CFO - MSN
Zura Bio names Eric Hyllengren as new CFO, effective July 7 - Investing.com
Zura Bio Announces Chief Financial Officer Transition - Business Wire
Zura Bio Limited(NasdaqCM: ZURA) dropped from Russell 2000 Dynamic Index - MarketScreener
Two Sigma Investments LP Decreases Stake in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Analysts Set Expectations for Zura Bio FY2026 Earnings - Defense World
Squarepoint Ops LLC Cuts Stock Position in Zura Bio Limited (NASDAQ:ZURA) - Defense World
ZURA Announces Upcoming Conference Call Hosted by Piper Sandler - GuruFocus
ZURA Announces Upcoming Conference Call Hosted by Piper Sandler | ZURA Stock News - GuruFocus
Two Sigma Advisers LP Invests $32,000 in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Millennium Management LLC Has $1.75 Million Position in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Northern Trust Corp Has $1.01 Million Stake in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Zura Bio Limited (NASDAQ:ZURA) Receives $14.33 Consensus Target Price from Analysts - Defense World
Zura Bio to Present at the Jefferies Global Healthcare Conference - Yahoo Finance
Zura Bio to Present at the Jefferies Global Healthcare Conference 2025 - BioSpace
Zura Bio shareholders approve board nominees and auditor - Investing.com Australia
Zura Bio shareholders approve board nominees and auditor By Investing.com - Investing.com South Africa
Q1 Earnings Forecast for Zura Bio Issued By HC Wainwright - Defense World
Zura Bio commences Phase II trial of tibulizumab for hidradenitis suppurativa - Clinical Trials Arena
Zura Bio begins phase 2 trial for hidradenitis suppurativa treatment - Investing.com Australia
Zura Bio begins phase 2 trial for hidradenitis suppurativa treatment By Investing.com - Investing.com India
Zura Bio (ZURA) Initiates Phase 2 Study for Tibulizumab in HS Treatment | ZURA Stock News - GuruFocus
Cubist Systematic Strategies LLC Makes New $62,000 Investment in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa - Quantisnow
Dimensional Fund Advisors LP Acquires New Holdings in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Wells Fargo & Company MN Grows Stock Holdings in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Barclays PLC Boosts Stock Position in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Raymond James Financial Inc. Invests $371,000 in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Oppenheimer Lowers Zura Bio (NASDAQ:ZURA) Price Target to $17.00 - Defense World
ZURA Stock Rating Maintained; Price Target Lowered by Oppenheime - GuruFocus
ZURA: Oppenheimer Revises Price Target Amid Ongoing Trials | ZUR - GuruFocus
ZURA Stock Rating Maintained; Price Target Lowered by Oppenheimer | ZURA Stock News - GuruFocus
Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates - Yahoo Finance
Ratio Analysis: Unpacking Zura Bio Ltd (ZURA)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Zura Bio Ltd Inc. (ZURA) Price Performance: The Role of Share Buybacks and Stock Splits - investchronicle.com
Do investors need to be concerned about Zura Bio Ltd (ZURA)? - uspostnews.com
Geode Capital Management LLC Increases Stake in Zura Bio Limited (NASDAQ:ZURA) - Defense World
After losing 56% in the past year, Zura Bio Limited (NASDAQ:ZURA) institutional owners must be relieved by the recent gain - Yahoo
Zura Bio Ltd (ZURA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):